ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Indonesia's Kalbe Farma moves into clinical testing

Pharmaceutical giant taps Japanese partners for technology

Kalbe Farma's KALGen Innolab clinical laboratory in Jakarta

JAKARTA -- Indonesian pharmaceutical company Kalbe Farma is entering the clinical testing business with two Japanese companies to tap the country's growing demand for prevention of lifestyle-related diseases.

The foray marks a further diversification of Kalbe's business, which includes drugs, powdered milk and energy drinks. The company's pharmaceutical division, which accounts for about a quarter of total revenue, is facing pressure on margins as the government's universal healthcare program brings in more competition among drug makers.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more